JAGSNPHARM.NSJAGSNPHARM.NS
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-2.97%
↓ 140% below average
Average (39q)
7.42%
Historical baseline
Range
High:155.12%
Low:-157.49%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -2.97% |
| Q2 2025 | 32.15% |
| Q1 2025 | -22.46% |
| Q4 2024 | 74.73% |
| Q3 2024 | 30.10% |
| Q2 2024 | 78.64% |
| Q1 2024 | 155.12% |
| Q4 2023 | -157.49% |
| Q3 2023 | -2.49% |
| Q2 2023 | 18.14% |
| Q1 2023 | -14.07% |
| Q4 2022 | -5.78% |
| Q3 2022 | 12.88% |
| Q2 2022 | 25.97% |
| Q1 2022 | -14.96% |
| Q4 2021 | -9.01% |
| Q3 2021 | 7.63% |
| Q2 2021 | 21.29% |
| Q1 2021 | -13.38% |
| Q4 2020 | 11.80% |
| Q3 2020 | 48.95% |
| Q2 2020 | -11.75% |
| Q1 2020 | -22.75% |
| Q4 2019 | 8.13% |
| Q3 2019 | -3.08% |
| Q2 2019 | 9.40% |
| Q1 2019 | 2.17% |
| Q4 2018 | -2.21% |
| Q3 2018 | 16.23% |
| Q2 2018 | -1.65% |
| Q1 2018 | 20.60% |
| Q4 2017 | 32.51% |
| Q3 2017 | 4.03% |
| Q2 2017 | -37.71% |
| Q1 2017 | 19.73% |
| Q4 2016 | -25.40% |
| Q3 2016 | -3.48% |
| Q2 2016 | -3.77% |
| Q1 2016 | 13.42% |
| Q4 2015 | 7.54% |